Development of Anti-Cancer Agents: Advances in Chemistry and Analysis
A special issue of International Journal of Molecular Sciences (ISSN 1422-0067). This special issue belongs to the section "Molecular Pharmacology".
Deadline for manuscript submissions: closed (31 March 2025) | Viewed by 1770
Special Issue Editor
Interests: medicinal chemistry; chemical biology; bioactive compounds; therapeutic applications in cancer and neuroscience; compounds design; targeting molecular pathways; biochemical interactions; disease mechanisms and treatment efficacy
Special Issues, Collections and Topics in MDPI journals
Special Issue Information
Dear Colleagues,
The Special Issue aims to showcase recent advancements in the development of anti-cancer agents, focusing on innovative approaches in both chemistry and analytical methodologies. Research contributions may cover novel synthetic routes, structure–activity relationship (SAR) studies, target validation, and mechanistic insights into anti-cancer drug development. Additionally, the issue will explore cutting-edge analytical techniques that enhance the precision and reliability of drug characterization, bioavailability studies, pharmacokinetics, and efficacy evaluations. This issue invites contributions that bridge the gap between chemistry-driven drug design and analytical advances to accelerate the discovery of effective cancer therapeutics.
Cancer-drug discovery and development continue to benefit from transformative advancements in chemistry and analytical sciences. This Special Issue, "Development of Anti-Cancer Agents: Advances in Chemistry and Analysis," seeks to highlight innovative work in both the synthetic and analytical domains that drive the development of more effective cancer treatments. Topics of interest include new chemical approaches for creating targeted therapies, structure–activity relationship (SAR) exploration, and insights into molecular mechanisms. We also welcome studies on analytical methods that improve pharmacokinetic profiling, metabolic stability, and in vivo efficacy assessments. By bringing together advancements in chemistry and state-of-the-art analytical techniques, this issue aims to present a comprehensive view of the current landscape and future potential for anti-cancer drug development.
Dr. Sridhar Nerella
Guest Editor
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. International Journal of Molecular Sciences is an international peer-reviewed open access semimonthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. There is an Article Processing Charge (APC) for publication in this open access journal. For details about the APC please see here. Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- anti-cancer agents
- medicinal chemistry
- structure–activity relationship (SAR)
- cancer therapeutics
- drug discovery and development
- pharmacokinetics
- targeted therapy
- analytical techniques
- bioavailability
- molecular mechanisms of cancer
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- Reprint: MDPI Books provides the opportunity to republish successful Special Issues in book format, both online and in print.
Further information on MDPI's Special Issue policies can be found here.
